Skip to main content
OpenTrials
Completed

NCT Number: NCT07469930

Psychometric Evaluation of a Dutch Attribution Questionnaire for Trauma-Related Attributions

A newly developed Dutch-language questionnaire was designed to assess trauma-related attributional styles across four theoretically derived dimensions: locus of causality, controllability, stability, and globality. This study evaluates the psychometric properties of the instrument in both a non-clinical student sample and a clinical sample receiving inpatient or outpatient treatment for trauma-related disorders. Analyses will include internal consistency, factor structure, item performance, and construct validity through associations with PTSD symptoms and trauma-related cognitions.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Reinier van Arkel, Psychotraumacentrum Zuid-Nederland

's-Hertogenbosch, North Brabant, 5211LJ, Netherlands

About this study

This study investigates the psychometric properties of a newly developed Dutch attribution questionnaire specifically designed to assess trauma-related attributional styles. The instrument includes 32 dichotomously scored items divided across general and personal attributional perspectives, each covering four attribution dimensions: locus of causality, controllability, stability, and globality.

Two samples were included: (1) a non-clinical sample of first-year psychology students from Radboud University (N = 418 in Part I; N = 382 in Part II), and (2) a clinical sample of individuals receiving inpatient or outpatient mental healthcare for trauma-related conditions at the Psychotraumacentrum Zuid-Nederland (PTC ZN; N = 112). All participants provided informed consent, and the study was approved by the relevant institutional ethics committee.

Participants completed the new questionnaire along with established measures of PTSD symptoms (PCL-5), trauma-related cognitions (PTCI), and general locus of control (IE-18; non-clinical sample only). Data were collected via secure online platforms. Analyses will include descriptive statistics, internal consistency (Cronbach's alpha), exploratory and confirmatory factor analyses, item response theory modelling, and correlation analyses to assess construct, convergent, and divergent validity. Group comparisons (clinical vs. non-clinical) and within-subject contrasts between general and personal attribution perspectives will be conducted using t-tests, MANOVAs, repeated measures ANOVAs, and regression models. Moderation and mediation analyses will examine the role of perspective contrast in predicting PTSD severity.

The study is guided by the following a priori hypotheses:

  • The questionnaire will demonstrate a clear and theoretically consistent factor structure reflecting the attribution dimensions of locus of causality, controllability, stability, and globality.
  • The total scale and subscales will show adequate internal consistency, with Cronbach's α values of at least .70.
  • Higher levels of maladaptive attributional patterns will be positively associated with PTSD symptom severity (PCL-5) and negative trauma-related cognitions (PTCI).
  • Personal attribution items will show stronger associations with psychopathology than general attribution items, reflecting the heightened impact of self-referential cognitive biases.
  • Clinical participants with trauma-related disorders will score higher on maladaptive attribution patterns than non-clinical students, indicating the instrument's sensitivity to trauma-related cognitive profiles.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18
  • Sufficient proficiency in Dutch
  • For clinical sample: history of traumatic exposure and current trauma-related symptoms
  • For non-clinical sample: enrollment as first-year psychology student at Radboud University

Exclusion criteria

  • Incomplete questionnaire data
  • Cognitive impairment preventing informed consent or questionnaire completion

Treatment and study plan

Primary outcomes

  1. 1. Change in Maladaptive Attributional Style (Dutch Attribution Questionnaire for Trauma-Related Attributions)

    Time frame: Baseline

    The Dutch Attribution Questionnaire for Trauma-Related Attributions is a 32-item self-report instrument assessing attributional patterns across four dimensions (locus of causality, controllability, stability, globality) from both general and personal perspectives. Items are scored dichotomously (0 = disagreement; 1 = agreement), yielding a total score ranging from 0 to 32. Higher scores indicate stronger maladaptive attributional patterns. Change from baseline to the specified follow-up point will be calculated.

Secondary outcomes

  1. 2. Change in PTSD Symptom Severity (PCL-5)

    Time frame: Baseline

    The PTSD Checklist for DSM-5 (PCL-5) is a 20-item self-report measure assessing PTSD symptom severity over the past month. Total scores range from 0 to 80, with higher scores indicating more severe symptoms. Change from baseline to follow-up will be calculated.

  2. 3. Change in Trauma-Related Cognitions (PTCI)

    Time frame: Baseline

    The Posttraumatic Cognitions Inventory (PTCI) assesses negative trauma-related cognitions about the self, the world, and self-blame. Total scores range from 33 to 231, with higher scores indicating more negative cognitions. Change from baseline to follow-up will be calculated.

Other outcomes

  1. 4. Change in General Locus of Control (IE-18)

    Time frame: Baseline

    The IE-18 is a shortened version of the Internal-External Control Scale, measuring general locus of control. Scores range from 0 to 18, with higher scores indicating a more external locus of control. This measure is administered only in the non-clinical sample. Change from baseline to follow-up will be assessed.

Sponsors and collaborators

Lead sponsor

Reinier van Arkel

Other

Registry information

Acronym: PEDAQTRA

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Mar 13, 2026
Registry last updated
Mar 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.